IL85955A - A cytoplasmic antigen is attributed to human cancer An antibody that binds to that antigen, a method for diagnosing human cancer in vitro, and a distant preparation or diagnostic agent that includes - Google Patents
A cytoplasmic antigen is attributed to human cancer An antibody that binds to that antigen, a method for diagnosing human cancer in vitro, and a distant preparation or diagnostic agent that includesInfo
- Publication number
- IL85955A IL85955A IL8595588A IL8595588A IL85955A IL 85955 A IL85955 A IL 85955A IL 8595588 A IL8595588 A IL 8595588A IL 8595588 A IL8595588 A IL 8595588A IL 85955 A IL85955 A IL 85955A
- Authority
- IL
- Israel
- Prior art keywords
- antibody
- antigen
- human
- april
- diagnostic agent
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/42—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins
- C07K16/4208—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig
- C07K16/4241—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig against anti-human or anti-animal Ig
- C07K16/4258—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig against anti-human or anti-animal Ig against anti-receptor Ig
- C07K16/4266—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig against anti-human or anti-animal Ig against anti-receptor Ig against anti-tumor receptor Ig
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/46—Hybrid immunoglobulins
- C07K16/468—Immunoglobulins having two or more different antigen binding sites, e.g. multifunctional antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S436/00—Chemistry: analytical and immunological testing
- Y10S436/811—Test for named disease, body condition or organ function
- Y10S436/813—Cancer
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Toxicology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Animal Behavior & Ethology (AREA)
- Cell Biology (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DK169987A DK169987D0 (da) | 1987-04-03 | 1987-04-03 | Human tumor-associated antigen, ca-ou1 |
Publications (2)
Publication Number | Publication Date |
---|---|
IL85955A0 IL85955A0 (en) | 1988-09-30 |
IL85955A true IL85955A (en) | 1994-12-29 |
Family
ID=8107312
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL8595588A IL85955A (en) | 1987-04-03 | 1988-04-01 | A cytoplasmic antigen is attributed to human cancer An antibody that binds to that antigen, a method for diagnosing human cancer in vitro, and a distant preparation or diagnostic agent that includes |
Country Status (14)
Country | Link |
---|---|
US (1) | US5338661A (ko) |
EP (1) | EP0285173B1 (ko) |
JP (1) | JPH082920B2 (ko) |
KR (1) | KR890700358A (ko) |
AU (1) | AU618260B2 (ko) |
DE (1) | DE3884646T2 (ko) |
DK (1) | DK169987D0 (ko) |
ES (1) | ES2059418T3 (ko) |
FI (1) | FI894650A (ko) |
IE (1) | IE60993B1 (ko) |
IL (1) | IL85955A (ko) |
NZ (1) | NZ224156A (ko) |
WO (1) | WO1988007377A1 (ko) |
ZA (1) | ZA882353B (ko) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU619226B2 (en) * | 1987-09-28 | 1992-01-23 | Children's Hospital Medical Center | Human cell lines of epithelial lung adenocarcinoma origin, human proteins and methods |
US5118611A (en) * | 1988-07-25 | 1992-06-02 | Adeza Biomedical Corporation | Adenocarcinoma antigen binding methods and reagents |
CA2015862A1 (en) * | 1989-05-04 | 1990-11-04 | Gajanan Nilaver | Cell surface antigen that binds with l6 monoclonal antibody |
EP0672253A4 (en) * | 1992-01-29 | 1995-12-06 | Sci Clone Inc | MONOCLONAL ANTIBODIES AGAINST CARCINOMA ASSOCIATED ANTI-SKI, METHOD FOR THEIR PRODUCTION AND THEIR USE. |
US5834215A (en) * | 1994-10-05 | 1998-11-10 | The Administrators Of The Tulane Educational Fund | Method for detecting antipolymer antibodies and diagnosing silicone related disease (SRD) fibromyalgia and chronic fatigue syndrome (CFS) |
US5744585A (en) * | 1995-03-16 | 1998-04-28 | Medenica; Rajko D. | Human monoclonal antibody against lung carcinoma |
AU4094297A (en) | 1996-08-30 | 1998-03-19 | Auburn University | Monoclonal antibodies specific to cooked meats |
US6288215B1 (en) * | 1996-08-30 | 2001-09-11 | Auburn University | Monoclonal antibodies specific to cooked meats |
US20020127584A1 (en) * | 1997-09-18 | 2002-09-12 | Genentech, Inc. | Secreted and transmembrane polypeptides and nucleic acids encoding the same |
EP1381631B1 (en) * | 2001-04-24 | 2010-10-13 | Bayer Corporation | Human anti timp-1 antibodies |
AU2002327704A1 (en) * | 2001-09-21 | 2003-04-01 | Raven Biotechnologies, Inc. | Antibodies that bind to cancer-associated antigen cytokeratin 8 and methods of use thereof |
EP1461001A4 (en) * | 2002-01-03 | 2010-03-31 | Scripps Research Inst | EPITOPE ASSOCIATED WITH CANCER |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4468457A (en) * | 1981-06-01 | 1984-08-28 | David M. Goldenberg | Method for producing a CSAp tryptic peptide and anti-CSAp antibodies |
US4579827A (en) * | 1983-03-11 | 1986-04-01 | Sloan-Kettering Institute For Cancer Research | Monoclonal antibodies to human gastrointestinal cancers and hybridoma method of production of the monoclonal antibodies |
NZ210867A (en) * | 1984-01-31 | 1989-01-06 | Litton Bionetics Inc | Tumour-specific monoclonal antibodies, production thereof and use |
GR850552B (ko) * | 1984-03-07 | 1985-07-05 | Du Pont | |
US4761377A (en) * | 1984-10-15 | 1988-08-02 | The Regents Of The University Of California | Human-human hybrid cell lines that produce antibodies against antigenic determinants on cancer cells |
ES8800604A1 (es) * | 1985-04-22 | 1987-11-16 | Hybritech Inc | Un metodo para producir anticuerpos monoclonales |
NO861491L (no) * | 1985-04-22 | 1986-10-23 | Hybritech Inc | Antistoff, fremgangsmaate for dets fremstilling og anvendelse for deteksjon og diagnose av canser. |
EP0242154B1 (en) * | 1986-04-17 | 1993-03-03 | Hybritech Incorporated | A novel tumor-associated antigen |
-
1987
- 1987-04-03 DK DK169987A patent/DK169987D0/da active IP Right Review Request
-
1988
- 1988-03-30 JP JP63503303A patent/JPH082920B2/ja not_active Expired - Lifetime
- 1988-03-30 US US07/411,469 patent/US5338661A/en not_active Expired - Fee Related
- 1988-03-30 WO PCT/DK1988/000059 patent/WO1988007377A1/en active Application Filing
- 1988-03-30 AU AU15965/88A patent/AU618260B2/en not_active Ceased
- 1988-03-31 IE IE97688A patent/IE60993B1/en not_active IP Right Cessation
- 1988-03-31 EP EP88105299A patent/EP0285173B1/en not_active Expired - Lifetime
- 1988-03-31 DE DE88105299T patent/DE3884646T2/de not_active Expired - Fee Related
- 1988-03-31 ZA ZA882353A patent/ZA882353B/xx unknown
- 1988-03-31 ES ES88105299T patent/ES2059418T3/es not_active Expired - Lifetime
- 1988-04-01 IL IL8595588A patent/IL85955A/en not_active IP Right Cessation
- 1988-04-06 NZ NZ224156A patent/NZ224156A/en unknown
- 1988-12-02 KR KR1019880701592A patent/KR890700358A/ko not_active Application Discontinuation
-
1989
- 1989-10-02 FI FI894650A patent/FI894650A/fi not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
EP0285173A2 (en) | 1988-10-05 |
ES2059418T3 (es) | 1994-11-16 |
EP0285173B1 (en) | 1993-10-06 |
EP0285173A3 (en) | 1990-01-31 |
FI894650A0 (fi) | 1989-10-02 |
DE3884646T2 (de) | 1994-01-27 |
IL85955A0 (en) | 1988-09-30 |
AU618260B2 (en) | 1991-12-19 |
ZA882353B (en) | 1988-09-23 |
DE3884646D1 (de) | 1993-11-11 |
US5338661A (en) | 1994-08-16 |
JPH02503383A (ja) | 1990-10-18 |
FI894650A (fi) | 1989-10-02 |
AU1596588A (en) | 1988-11-02 |
IE60993B1 (en) | 1994-09-07 |
KR890700358A (ko) | 1989-04-24 |
DK169987D0 (da) | 1987-04-03 |
IE880976L (en) | 1988-10-03 |
JPH082920B2 (ja) | 1996-01-17 |
NZ224156A (en) | 1991-07-26 |
WO1988007377A1 (en) | 1988-10-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US4446122A (en) | Purified human prostate antigen | |
JP3541296B2 (ja) | 腫瘍血管内皮細胞に特異的に結合するモノクローナル抗体とその利用方法 | |
US4708930A (en) | Monoclonal antibody to a human carcinoma tumor associated antigen | |
USRE33405E (en) | Purified human prostate antigen | |
AU612967B2 (en) | Monoclonal antibodies and antigen for human non-small cell lung carcinoma and certain other human carcinomas | |
NZ214542A (en) | Monoclonal antibodies and antigen for human non-small cell lung carcinomas | |
CA2072620C (en) | Urinary tumor associated antigen, antigenic subunits uses and methods of detection | |
EP0285173B1 (en) | Human carcinoma-associated antigen and antibody binding to the antigen | |
AU677120B2 (en) | Monoclonal antibodies against tumor-associated antigens, a process for the preparation thereof and the use thereof | |
CA1165685A (en) | Purified prostatic tissue antigen | |
Bankert et al. | Screening and replica plating of anti-hapten hybridomas with a transfer template hemolytic spot assay | |
US5073493A (en) | Monoclonal antibody nky13 | |
JPH05506241A (ja) | 35kd腫瘍関連タンパク質抗原および免疫複合体 | |
JP4493882B2 (ja) | 抗原およびこの抗原を識別するモノクローナル抗体 | |
LV10202B (en) | Human carcinoma-associated antigen and antibody binding to the antigen | |
JPH02219594A (ja) | 肺癌に対するモノクローナル抗体および細胞表面抗原 | |
NO176903B (no) | Antistoff eller bindende fragment derav til diagnostikk av humant carcinom, eller som transportör av farmasöytiske midler, isolert, humant tumor-assosiert antigen, diagnostisk middel og fremgangsmåte for in vitro-diagnostisering | |
DK162844B (da) | Antistof mod et humant carcinom-associeret antigen, et saadant humant carcinom-associeret antigen, et anti-idiotypisk antistof rettet mod antistoffet, et anti-anti-idiotypisk antistof rettet mod det anti-idiotypiske antistof, et diagn. middel, der omfatter antistoffet eller antigenet, fremg.maade til fremstil. af et monoklonalt antistof mod et carcinom-accocieret antigen, fremg.maade til in med mere | |
JPH0630620B2 (ja) | 人体液中に存在する分子量7万〜30万のコリンエステラーゼに反応するモノクローナル抗体 | |
JPH06107695A (ja) | 新規ヒト血液細胞関連抗原及びそれを認識する単クローン抗体 | |
JPS62500699A (ja) | ヒトの癌腫瘍関連抗原に対する単クロ−ン性抗体 | |
JPH03155796A (ja) | TGF―αに対するモノクローナル抗体 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RH | Patent void |